Abstract
Imidocarb dipropionate is a carbanilide derivative antiprotozoan drug. The drug is approved for use in animals for the treatment of tick-borne transmitted babesiosis (piroplasmosis) and anaplasmosis. However, its effectiveness against some other microorganisms transmitted by ticks has also been investigated. Although cattle, horses, donkeys, mules, dogs and sheep are defined as target species, they can also be used in other domestic and wild animals. Although it is recommended to use the drug as a single dose, it can be applied 2-3 days later if necessary. The therapeutic index of the drug is narrow, and attention should be paid to the dosage regimen. In this review, it could be tried to give information about the use of imidocarb in animal species, its success in treatment and its side effects.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Veteriner Farmakoloji ve Toksikoloji Derneği Bülteni
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
